Epstein-barr virus-associated hemophagocytic lymphohistiocytosis: A retrospective study of 78 pediatric cases in mainland of China

Chinese Medical Journal

Volumn 123, Issue 11, 2010, Pages 1426-1430

  Jin, Ying Kang ^a   Xie, Zheng De ^a   Yang, Shuang ^a   Lu, Gen ^a   Shen, Kun Ling ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Epstein barr virus; Hemophagocytic lymphohistiocytosis; Risk factors

Indexed keywords

CELL NUCLEUS ANTIGEN; CORTICOSTEROID; GANCICLOVIR; INTERFERON;

ANEMIA; ARTICLE; BLEEDING; BONE MARROW BIOPSY; CHILD; CHINESE; CLINICAL FEATURE; COMA; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EDEMA; EPSTEIN BARR VIRUS; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; JAUNDICE; LUNG EDEMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NATURAL KILLER CELL; NEUTROPENIA; OPISTHOTONUS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SEPSIS; SEPTICEMIA; SEROLOGY; SIGNAL TRANSDUCTION; SPLENOMEGALY; SURVIVAL RATE; THROMBOCYTOPENIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953511844     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.11.014     Document Type: Article

References (23)

1. Sullivan KE, Delaat CA, Douglas SD, Filipovich AH. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first-degree relatives. Pediatr Res 1998; 44: 465-468.
2. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
3. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr 1991; 80: 428-435.
4. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435-444.
5. Sullivan JL, Woda BA, Herrod HQ Koh G, Rivara FP, Mulder C. Epstein-Barr virus associated hemophagocytic syndrome: virological and immunopathological studies. Blood 1985; 65: 1097-1104.
6. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistio-cytosis. Crit Rev Oncol Hemat 2002; 44: 259-272.
7. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987; 111: 530-535.
8. Ross CW, Schnitzer B, Weston BW, Hanson CA. Chronic ctive Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991; 115: 70-474.
9. Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus associated peripheral T cell lymphoma. Cancer 1993; 72: 09-916.
10. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of pstein-Barr virus-associated hemophagocytic lymphohistio- ytosis. J Clin Oncol 2001; 19: 2665-2673.
11. Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, agashima T, et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 1993; 82: 3259-3264.
12. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic yndrome in Epstein-Barr virus-associated T-lymphopro-liferative disorders: disease spectrum, pathogenesis, and management. Leukemia Lymphoma 1995; 19: 401-406.
13. Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996; 53: 111-115.
14. Henter JI, Horne A, Arico M, Maarten RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr lood Cancer 2007; 48: 124-131.
15. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit ev Oncol Hematol 2002; 44: 283-294.
16. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993; 92: 1444-1450.
17. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007; 7: 814-822.
18. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated erritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood Cancer 2007; 50: 227-1235.
19. Chateil JF, Brun M, Perel Y, Pillet P, Micheau M, Diard F. Abdominal ultrasound findings in children with hemophagocytic lymphohistiocytosis. Eur Radiol 1999; 9: 474-477.
20. Schmidt MH, Sung L, Shuckett BM. Hemophagocytic lymphohistiocytosis in children: abdominal US findings within 1 week of presentation. Radiology 2004; 230: 685-689.
21. Fitzgerald NE, McClain KL. Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 2003; 33: 392-401.
22. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130: 352-357.
23. Imashuku S, Teramura T, Tauchi H, Ishida Y, Otoh Y, Sawada M, et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004; 89: 183-188.